Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cefazolin + vancomycin versus ceftazidime + vancomycin for surgical site infection prophylaxis in open-heart surgery
IRCT20120215009014N324Phase 2Completed
- Sponsor
- Hamadan University of Medical Sciences
- Start
- Jan 2020
- Modality
- Antimicrobial Peptides → Native Peptides → Peptides, Cyclic Peptides → Modified Peptides → Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in surgical site infection (SSI) comparing Cefazolin + vancomycin with Ceftazidime + vancomycin (2 arms). Primary endpoint: Superficial infection at the surgical site. Started Jan 2020; status: completed.
02
Drugs
cefazolinvancomycinceftazidime
03
Conditions
surgical site infection (SSI)
Beyond the preview
Go deeper on IRCT20120215009014N324.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20120215009014N324.